Suppression of recurrent transient ischemic attacks by a statin agent

被引：9

作者：

Alberts, MJ ^{[1
]}

机构：

[1] Duke Univ, Med Ctr, Stroke Acute Care Unit, DUMC 3392, Durham, NC 27710 USA

来源：

NEUROLOGY | 2001年 / 56卷 / 04期

关键词：

D O I：

10.1212/WNL.56.4.531

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

Recent studies of hydroxy-methylglutaryl coenzyme A reductase inhibitors have demonstrated that therapy with statins is associated with a significant decrease in the risk of stroke and TIA in patients with coronary artery disease. The underlying mechanism responsible for this effect is unclear. The author presents two patients who had cessation of TIAs upon institution of statin therapy. A variety of non-lipid-lowering mechanisms may account far this beneficial effect. This initial observation, if confirmed by further study, may suggest a role far statin agents in preventing recurrent TIAs.

引用

页码：531 / 532

页数：2

共 10 条

[1]

Byington RP, 1999, CIRCULATION, V100, pE14

[2] HMG-CoA reductase inhibitor therapy and stroke risk reduction: an analysis of clinical trials data [J].

Crouse, JR ;

Byington, RP ;

Furberg, CD .

ATHEROSCLEROSIS, 1998, 138 (01) :11-24

[3] Vascular effects of statins in stroke [J].

Delanty, N ;

Vaughan, CJ .

STROKE, 1997, 28 (11) :2315-2320

[4]

PEDERSEN TR, 1994, LANCET, V344, P1383

[5] Reduction of stroke incidence after myocardial infarction with pravastatin -: The cholesterol and recurrent events (CARE) study [J].

Plehn, JF ;

Davis, BR ;

Sacks, FM ;

Rouleau, JL ;

Pfeffer, MA ;

Bernstein, V ;

Cuddy, TE ;

Moyé, LA ;

Piller, LB ;

Rutherford, J ;

Simpson, LM ;

Braunwald, E .

CIRCULATION, 1999, 99 (02) :216-223

[6] Antiatherothrombotic properties of statins - Implications for cardiovascular event reduction [J].

Rosenson, RS ;

Tangney, CC .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1998, 279 (20) :1643-1650

[7] The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels [J].

Sacks, FM ;

Pfeffer, MA ;

Moye, LA ;

Rouleau, JL ;

Rutherford, JD ;

Cole, TG ;

Brown, L ;

Warnica, JW ;

Arnold, JMO ;

Wun, CC ;

Davis, BR ;

Braunwald, E .

NEW ENGLAND JOURNAL OF MEDICINE, 1996, 335 (14) :1001-1009

[8] Effects of pravastatin sodium and simvastatin on plasma fibrinogen level and blood rheology in type II hyperlipoproteinemia [J].

Tsuda, Y ;

Satoh, K ;

Kitadai, M ;

Takahashi, T ;

Izumi, Y ;

Hosomi, N .

ATHEROSCLEROSIS, 1996, 122 (02) :225-233

[9]

WADA H, 1992, CLIN THER, V14, P829

[10] Pravastatin therapy and the risk of stroke. [J].

White, HD ;

Simes, RJ ;

Anderson, NE ;

Hankey, GJ ;

Watson, JDG ;

Hunt, D ;

Colquhoun, DM ;

Glasziou, P ;

MacMahon, S ;

Kirby, AC ;

West, MJ ;

Tonkin, AM .

NEW ENGLAND JOURNAL OF MEDICINE, 2000, 343 (05) :317-326

← 1 →